李-佛美尼综合征患者癌症治疗期间基因组不稳定性增加
本文报告一名4岁李-佛美尼综合征(LFS)患儿在接受颅脊髓照射治疗转移性脉络丛癌期间,其p53缺陷淋巴细胞无法发生辐射诱导的细胞周期阻滞或凋亡,DNA修复能力未受损但持续积累53BP1焦点和复杂染色体畸变,提示放疗可导致造血系统进行性基因组不稳定性。
要点
- LFS患者p53缺陷淋巴细胞在辐射后不能诱导细胞周期阻滞或凋亡。
- 放疗期间及之后数月p53缺陷淋巴细胞持续积累53BP1焦点,反映DNA损伤未修复。
- mFISH显示颅脊髓照射后p53缺陷淋巴细胞出现大量复杂染色体畸变。
核心结论
- p53通过促进细胞周期检查点和凋亡在维持基因组稳定性中起核心作用。
- LFS患者接受颅脊髓照射(包括大体积骨髓)后造血系统出现进行性基因组不稳定性。
- 放疗期间p53缺陷使增殖性干/祖细胞的基因组稳定机制受干扰,增加癌症起始和进展风险。
研究设计与样本
- 病例报告:一名4岁男性LFS患儿(生殖系p53杂合突变)因转移性脉络丛癌接受肿瘤切除、全身化疗和全颅脊髓轴照射。
- 对照比较:采集LFS患者(p53缺陷)与年龄匹配的肿瘤患儿(p53正常)在颅脊髓照射前、中、后的血液淋巴细胞,并与未接受DNA损伤治疗的同种p53突变无症状携带者比较。
主要发现
- p53缺陷淋巴细胞中辐射诱导的DNA损伤未能诱导细胞周期阻滞或凋亡。
- DNA修复能力未受损,但p53缺陷淋巴细胞在照射期间及照射后数月仍显著积累53BP1焦点,反映持续性DNA损伤。
- 电子显微镜显示从简单未修复病变到染色体异常的DNA异常。
- mFISH中期染色体扩散显示颅脊髓照射后p53缺陷淋巴细胞出现大量复杂染色体畸变。
临床怎么用
- 对LFS等p53缺陷患者进行DNA损伤性放疗时,需关注造血系统基因组不稳定性风险。
- 放疗期间及之后可考虑监测p53缺陷患者淋巴细胞的DNA损伤反应和染色体畸变。
局限性
- 本文为单例病例报告,结论需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Li-Fraumeni syndrome (LFS) is a cancer predisposition disorder characterized by germline mutations of the p53 tumor-suppressor gene. In response to DNA damage, p53 stimulates protective cellular processes including cell-cycle arrest and apoptosis to prevent aberrant cell proliferation. Current cancer therapies involve agents that damage DNA, which also affect non-cancerous hematopoietic stem/progenitor cells. Here, we report on a child with LFS who developed genomic instability during craniospinal irradiation for metastatic choroid plexus carcinoma (CPC). CASE PRESENTATION: This previously healthy 4-year-old boy presented with parieto-temporal brain tumor, diagnosed as CPC grade-3. Screening for cancer-predisposing syndrome revealed heterozygous p53 germline mutation, leading to LFS diagnosis. After tumour resection and systemic chemotherapy, entire craniospinal axis was irradiated due to leptomeningeal seeding, resulting in disease stabilization for nearly 12 months. Blood lymphocytes of LFS patient (p53-deficient) and age-matched tumor-children (p53-proficient) were collected before, during and after craniospinal irradiation and compared with asymptomatic carriers for identical p53 mutation, not exposed to DNA-damaging treatment. In p53-deficient lymphocytes of LFS patient radiation-induced DNA damage failed to induce cell-cycle arrest or apoptosis. Although DNA repair capacity was not impaired, p53-deficient blood lymphocytes of LFS patient showed significant accumulation of 53BP1-foci during and even several months after irradiation, reflecting persistent DNA damage. Electron microscopy revealed DNA abnormalities ranging from simple unrepaired lesions to chromosomal abnormalities. Metaphase spreads of p53-deficient lymphocytes explored by mFISH revealed high amounts of complex chromosomal aberrations after craniospinal irradiation. CONCLUSIONS: Tumor suppressor p53 plays a central role in maintaining genomic stability by promoting cell-cycle checkpoints and apoptosis. Here, we demonstrate that a patient with LFS receiving craniospinal irradiation including large volumes of bone marrow developed progressive genomic instability of the hematopoietic system. During DNA-damaging radiotherapy, genome-stabilizing mechanisms in proliferating stem/progenitor cells are perturbed by p53 deficiency, increasing the risk of cancer initiation and progression.
引用
- Schuler N, Palm J, Schmitz S, et al. Increasing genomic instability during cancer therapy in a patient with Li-Fraumeni syndrome. Clin Transl Radiat Oncol. 2017. PMID: 29594232. doi:10.1016/j.ctro.2017.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。